Fabbri C.; Jaboli F.; Giovanelli S.; Azzaroli F.; Pezzoli A.; Accogli E.; Liva S.; Nigro G.; Miracolo A.; Festi D.; Colecchia A.; Montagnani M.; Roda E.; Mazzella G., Gastric autoimmune disorders in patients with chronic hepatitis C before, during the after interferon-alpha therapy, «WORLD JOURNAL OF GASTROENTEROLOGY», 2003, 9, pp. 1487 - 1490 [articolo]
Jaboli M.F.; Fabbri C.; Liva S.; Azzaroli F.; Nigro G.; Giovanelli S.; Ferrara F.; Miracolo A.; Marchetto S.; Montagnani M.; Colecchia A.; Festi D.; Reggiani L.B.; Roda E.; Mazzella G., Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: Results of an open, controlled trial, «WORLD JOURNAL OF GASTROENTEROLOGY», 2003, 9, pp. 1491 - 1495 [articolo]
Bazzoli F.; Palli D.; Zagari R.M.; Festi D.; Pozzato P.; Nicolini G.; Masala G.; Fossi S.; Ricciardiello L.; Panuccio D.; Roda E., The Loiano-Monghidoro population-based study of Helicobacter pylori infection: Prevalence by 13C-urea breath test and associated factors, «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2001, 15, pp. 1001 - 1007 [articolo]
Jaboli, F; Fabbri, C; Marchetto, S; Mazzeo, C; Azzaroli, F; Pezzoli, A; Colecchia, A; Festi, D; Romano, F; Roda, E; Mazzella, G, Efficacy and safety of long term treatment of chronic hepatitis B with IFNA plus lamivudine versus IFNA alone, «GASTROENTEROLOGY», 2000, 118, pp. A937 - A937 [replica/breve intervento]
Fabbri C.; Marchetto S.; Pezzoli A.; Accogli E.; Fusaroli P.; Azzaroli F.; Jaboli M.F.; Mazzeo C.; Montagnani M.; Festi D.; Roda E.; Mazzella G., Efficacy of ursodeoxycholic acid in association with α-interferon for chronic hepatitis C in α-interferon non-responder patients, «EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY», 2000, 12, pp. 511 - 515 [articolo]
Mazzella G.; Saracco G.; Festi D.; Rosina F.; Marchetto S.; Jaboli F.; Sostegni R.; Pezzoli A.; Azzaroli F.; Cancellieri C.; Montagnani M.; Roda E.; Rizzetto M., Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial, «THE AMERICAN JOURNAL OF GASTROENTEROLOGY», 1999, 94, pp. 2246 - 2250 [articolo]
Mazzella G.; Fusaroli P.; Pezzoli A.; Azzaroli F.; Mazzeo C.; Zambonin L.; Simoni P.; Festi D.; Roda E., Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile, «DIGESTIVE DISEASES AND SCIENCES», 1999, 44, pp. 2478 - 2483 [articolo]
Accogli, E; Trerè, D; Mazzella, G; Colecchia, A; Sottili, S; Casanova, S; Marchetto, S; Fabbri, C; Jaboli, F; Festi, D; Roda, E; Derenzini, M, The severity of HCV-related chronic hepatitis correlates with AgNOR protein expression while response to alpha interferon treatment is associated with its decrease, «GASTROENTEROLOGY», 1998, 114, pp. A1199 - A1199 [articolo]
Mazzella, G.; Accogli, E.; Sottili, S.; Festi, D.; Orsini, M.; Salzetta, A.; Novelli, V.; Cipolla, A.; Fabbri, C.; Pezzoli, A.; Roda, E., Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis, «JOURNAL OF HEPATOLOGY», 1996, 24, pp. 141 - 147 [articolo]
Mazzella, G; Accogli, E; Sottilli, S; Festi, D; Osrini, M; Salzetta, A; Novelli, V; Cipolla, A; Fabbri, C; Pezzoli, A; Roda, E, ALPHA-INTERFERON TREATMENT PREVENTS HEPATOCELLULAR-CARCINOMA IN HCV RELATED LIVER-CIRRHOSIS, «GASTROENTEROLOGY», 1995, 108, pp. A1120 - A1120 [articolo]
Mazzella G.; Cipolla A.; Villanova N.; Polimeni C.; Sipahi A.; Parini P.; Fusaroli P.; Festi D.; Roda E., Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects, «ITALIAN JOURNAL OF GASTROENTEROLOGY», 1995, 27, pp. 441 - 445 [articolo]
ALDINI R.; RODA A.; LENZI P.L.; USSIA G.; VACCARI M.C.; MAZZELLA G.; FESTI D.; BAZZOLI F.; GALLETTI G.; CASANOVA S.; MONTAGNANI M.; RODA E., Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring, «THE EUROPEAN JOURNAL OF CLINICAL INVESTIGATION», 1992, 22, pp. 744 - 750 [articolo]
